Animol Discovery Stock

We are a biopharmaceutical company focused on identifying and developing next- generation antiparasitics and therapeutics.

Sign up today and learn more about Animol Discovery Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Animol Discovery Stock

Animol is building its own pipeline of break-through proprietary veterinary small molecules led by a team of animal health industry experts with vast experience in bringing drugs to market. With our unique and powerful technology platform we deliver innovative medicines that are specifically designed for the needs of veterinary patients.

Funding History

January 2020$6.0M
July 2022$34.0M

Management

Board Member

Michelle Haven

Co-founder

Philip Austin

Member of Board of Directors

Philip Austin

Board Member

Marijn Dekkers

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo